Risk factors for cognitive dysfunction in prostate cancer patients undergoing androgen deprivation therapy: a retrospective study

Key Points

• Cognitive dysfunction risk is heightened in prostate cancer patients undergoing androgen deprivation therapy.
• Using a model that includes MoCA and psychological scores improves prediction accuracy for cognitive impairment risk.
• The retrospective study assesses various psychological scores, age, and MoCA to ascertain cognitive dysfunction risk.
• Findings indicate the necessity for targeted interventions to manage cognitive impacts during treatment.